Where we are with community-associated Staphylococcus aureus prevention--and in the meantime, what do we tell our patients?

Clin Infect Dis. 2012 Mar;54(6):752-4. doi: 10.1093/cid/cir922. Epub 2011 Dec 23.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carrier State / drug therapy*
  • Family Characteristics*
  • Female
  • Humans
  • Male
  • Soft Tissue Infections / drug therapy*
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcus aureus*